Australia markets closed

Getein Biotech, Inc (603387.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
9.04+0.04 (+0.44%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,445,655
1,821,861
1,401,701
1,123,336
Cost of revenue
523,508
636,392
482,461
415,297
Gross profit
922,147
1,185,468
919,240
708,039
Operating expenses
Research development
231,978
223,222
163,393
119,068
Selling general and administrative
390,717
338,179
263,478
208,687
Total operating expenses
678,916
630,419
482,911
360,757
Operating income or loss
243,231
555,050
436,329
347,282
Interest expense
17,447
16,607
14,312
6,222
Income before tax
269,566
559,979
451,633
374,040
Income tax expense
13,030
56,034
39,622
43,727
Income from continuing operations
256,536
503,945
412,011
330,313
Net income
252,779
498,910
398,990
304,733
Net income available to common shareholders
252,779
498,910
398,990
304,733
Basic EPS
0.50
0.98
0.79
0.60
Diluted EPS
0.50
0.98
0.78
0.60
Basic average shares
507,649
509,092
505,051
507,889
Diluted average shares
507,649
509,092
511,526
507,889